Aurora kinase B siRNA-loaded lactoferrin nanoparticles potentiate the efficacy of temozolomide in treating glioblastoma

被引:25
|
作者
Kumari, Sonali [1 ]
Bhattacharya, Dwaipayan [2 ]
Rangaraj, Nandini [3 ]
Chakarvarty, Sumana [3 ]
Kondapi, Anand K. [1 ]
Rao, Nalam M. [2 ]
机构
[1] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Prof CR Rao Rd, Hyderabad 500046, Telangana, India
[2] CSIR, Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad 500007, Telangana, India
[3] CSIR, CCMB, Uppal Rd, Hyderabad 500007, Telangana, India
关键词
blood-brain barrier; glioblastoma multiforme; nanoparticle; siRNA; temozolomide; MEDIATED TARGETED DELIVERY; CANCER STEM-CELLS; LIPID NANOPARTICLES; SYSTEMIC DELIVERY; MOUSE MODEL; GENE; DNA; DRUG; PHARMACOKINETICS; PHOSPHORYLATION;
D O I
10.2217/nnm-2018-0110
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aim: To investigate the efficacy of lactoferrin nanoparticles (LfNPs) in delivering siRNA across the bloodbrain barrier to treat glioblastoma multiforme (GBM) and with an additional objective of potentiation of conventional temozolomide (TMZ) chemotherapy. Methods: Aurora kinase B (AKB) siRNA-loaded nanoparticles (AKB-LfNPs) were prepared with milk protein, lactoferrin, by water in oil emulsion method. AKB-LfNPs were tested in cell lines and in GBM orthotopic mouse model with and without TMZ treatment. Results: AKB silencing, cytotoxicity and cell cycle arrest by these LfNPs were shown to be effective on GL261 cells. Tumor growth was significantly lower in AKB-LfNPs alone and in combination with TMZ treated mice and increased the survival by 2.5-times. Conclusion: Treatment of AKB-LfNPs to GBM mice improves life expectancy and has potential to combine with conventional chemotherapy.
引用
收藏
页码:2579 / 2596
页数:18
相关论文
共 12 条
  • [1] Aurora kinase inhibition to enhance Tumor Treating Fields efficacy in glioblastoma treatment
    Bartmann, Paula
    Roosz, Silvia
    Temme, Achim
    Giladi, Moshe
    Kirson, Eilon D.
    Plati, Yoram
    Weinberg, Uri
    Kinzel, Adrian
    Leidgens, Verena
    Krex, Dietmar
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Efficacy of siRNA-loaded nanoparticles in the treatment of K-RAS mutant lung cancer in vitro
    Gencer, Ayse
    Baysal, Ipek
    Nemutlu, Emirhan
    Yabanoglu-Ciftci, Samiye
    Arica, Betul
    JOURNAL OF MICROENCAPSULATION, 2022, 39 (03) : 261 - 275
  • [3] Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide
    Alafate, Wahafu
    Wang, Maode
    Zuo, Jie
    Wu, Wei
    Sun, Liangzhang
    Liu, Chao
    Xie, Wanfu
    Wang, Jia
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (11)
  • [4] EFFICACY OF TUMOR TREATING FIELDS (TTFIELDS) AND AURORA B KINASE INHIBITOR
    Krex, D.
    Bartmann, P.
    Temme, A.
    Schneiderman, R.
    Voloshin, T.
    Giladi, M.
    Kinzel, A.
    Kirson, E.
    Weinberg, U.
    Palti, Y.
    NEURO-ONCOLOGY, 2018, 20 : 292 - 292
  • [5] Efficacy of Tumor Treating Fields (TTFields) and Aurora B kinase inhibitor
    Krex, Dietmar
    Temme, Achim
    Schneiderman, Rosa S.
    Zeevi, Einav
    Gotlib, Karnit
    Voloshin, Tali
    Giladi, Moshe
    Kinzel, Adrian
    Kirson, Eilon D.
    Weinberg, Uri
    Plati, Yoram
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration
    Van Woensel, Matthias
    Wauthoz, Nathalie
    Rosiere, Remi
    Mathieu, Veronique
    Kiss, Robert
    Lefranc, Florence
    Steelant, Brecht
    Dilissen, Ellen
    Van Gool, StefaanW.
    Mathivet, Thomas
    Gerhardt, Holger
    Amighi, Karim
    De Vleeschouwer, Steven
    JOURNAL OF CONTROLLED RELEASE, 2016, 227 : 71 - 81
  • [7] Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation
    Danhier, Fabienne
    Messaoudi, Khaled
    Lemaire, Laurent
    Benoit, Jean-Pierre
    Lagarce, Frederic
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 481 (1-2) : 154 - 161
  • [8] A2B SiRNA-Loaded Nanoparticles Targeted to the Colon With Polysaccharide Hydrogel Reduces the Severity of Colitis in a Mouse Model
    Laroui, Hamed
    Dalmasso, Guillaume
    Garg, Pallavi
    Wang, Lixin
    Merlin, Didier
    Sitaraman, Shanthi V.
    GASTROENTEROLOGY, 2011, 140 (05) : S166 - S166
  • [9] ENHANCED EFFICACY OF TUMOR TREATING FIELDS AND AURORA B KINASE INHIBITOR COMBINATION IN GLIOMA CELL LINES
    Krex, Dietmar
    Bartmann, Paula
    Temme, Achim
    Schneiderman, Rosa S.
    Voloshin, Tali
    Giladi, Moshe
    Kinzel, Adrian
    Kirson, Eilon
    Plati, Yoram
    NEURO-ONCOLOGY, 2018, 20 : 264 - 264
  • [10] Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma
    Meteoglu, Irem
    Erdemir, Aysegul
    PROCESS BIOCHEMISTRY, 2021, 110 : 9 - 18